Teva Pharmaceutical Industries Limited (TEVA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 3.98B | 4.71B | 4.48B | 4.18B | 3.89B | 4.23B | 4.33B | 4.16B | 3.82B | 4.46B | 3.85B | 3.88B | 3.66B | 3.88B | 3.6B | 3.79B | 3.66B | 4.1B | 3.89B | 3.91B |
| Revenue Growth % | 2.31% | 11.4% | 3.44% | 0.29% | 1.89% | -5.12% | 12.49% | 7.37% | 4.32% | 14.78% | 7.09% | 2.43% | 0% | -5.29% | -7.51% | -3.17% | -8.06% | -7.93% | -2.29% | 1.03% |
| Cost of Goods Sold | 2.01B | 2.06B | 2.18B | 2.07B | 2.01B | 2.11B | 2.18B | 2.14B | 2.05B | 2.04B | 2B | 2.08B | 2.08B | 2.11B | 1.93B | 1.99B | 1.92B | 2.05B | 2.09B | 2.04B |
| COGS % of Revenue | 50.51% | 43.64% | 48.57% | 49.66% | 51.76% | 49.87% | 50.4% | 51.39% | 53.63% | 45.79% | 51.92% | 53.69% | 56.79% | 54.42% | 53.57% | 52.61% | 52.47% | 50% | 53.85% | 52.1% |
| Gross Profit | 1.97B | 2.66B | 2.3B | 2.1B | 1.88B | 2.12B | 2.15B | 2.02B | 1.77B | 2.42B | 1.85B | 1.8B | 1.58B | 1.77B | 1.67B | 1.79B | 1.74B | 2.05B | 1.79B | 1.87B |
| Gross Margin % | 49.54% | 56.38% | 51.43% | 50.34% | 48.24% | 50.13% | 49.6% | 48.61% | 46.37% | 54.21% | 48.08% | 46.31% | 43.21% | 45.58% | 46.43% | 47.39% | 47.53% | 50% | 46.15% | 47.9% |
| Gross Profit Growth % | 5.06% | 25.28% | 7.26% | 3.85% | 5.99% | -12.25% | 16.05% | 12.69% | 11.95% | 36.5% | 10.9% | 0.11% | -9.08% | -13.66% | -6.97% | -4.22% | -7.35% | 0.1% | -3.13% | 6.24% |
| Operating Expenses | 1.32B | 2.35B | 1.42B | 1.65B | 1.36B | 2.15B | 2.2B | 2.03B | 1.99B | 1.66B | 1.51B | 2.45B | 1.59B | 2.63B | 1.25B | 2.74B | 2.45B | 1.97B | 1.17B | 1.29B |
| OpEx % of Revenue | 33.11% | 49.99% | 31.74% | 39.44% | 34.9% | 50.82% | 50.77% | 48.73% | 52.08% | 37.24% | 39.14% | 63.18% | 43.57% | 67.6% | 34.77% | 72.45% | 67% | 48.1% | 30.13% | 33.02% |
| Selling, General & Admin | 1B | 1.12B | 973M | 959M | 919M | 952M | 924M | 939M | 886M | 902M | 844M | 910M | 842M | 837M | 822M | 907M | 880M | 908M | 888M | 857M |
| SG&A % of Revenue | 25.12% | 23.77% | 21.72% | 22.96% | 23.62% | 22.51% | 21.33% | 22.55% | 23.2% | 20.24% | 21.92% | 23.47% | 23% | 21.56% | 22.87% | 23.96% | 24.04% | 22.15% | 22.85% | 21.92% |
| Research & Development | 222M | 267M | 256M | 244M | 247M | 271M | 240M | 269M | 242M | 234M | 253M | 275M | 253M | 210M | 175M | 228M | 225M | 244M | 222M | 248M |
| R&D % of Revenue | 5.58% | 5.67% | 5.71% | 5.84% | 6.35% | 6.41% | 5.54% | 6.46% | 6.34% | 5.25% | 6.57% | 7.09% | 6.91% | 5.41% | 4.87% | 6.02% | 6.15% | 5.95% | 5.71% | 6.34% |
| Other Operating Expenses | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 652M | 300M | 882M | 455M | 519M | -29M | -51M | -5M | -218M | 756M | 344M | -654M | -13M | -855M | 419M | -949M | -713M | 78M | 623M | 582M |
| Operating Margin % | 16.38% | 6.37% | 19.69% | 10.9% | 13.34% | -0.69% | -1.18% | -0.12% | -5.71% | 16.96% | 8.94% | -16.86% | -0.36% | -22.02% | 11.66% | -25.07% | -19.48% | 1.9% | 16.03% | 14.88% |
| Operating Income Growth % | 25.63% | 1134.48% | 1829.41% | 9200% | 338.07% | -103.84% | -114.83% | 99.24% | -1576.92% | 188.42% | -17.9% | 31.09% | 98.18% | -1196.15% | -32.74% | -263.06% | -264.29% | -80.79% | 114.35% | 236.42% |
| EBITDA | 891M | 560M | 1.13B | 706M | 763M | 240M | 208M | 254M | 54M | 1.02B | 627M | -354M | 291M | -549M | 740M | -591M | -390M | 398M | 952M | 887M |
| EBITDA Margin % | 22.38% | 11.89% | 25.25% | 16.91% | 19.61% | 5.68% | 4.8% | 6.1% | 1.41% | 22.93% | 16.29% | -9.13% | 7.95% | -14.14% | 20.58% | -15.61% | -10.65% | 9.71% | 24.49% | 22.69% |
| EBITDA Growth % | 16.78% | 133.33% | 443.75% | 177.95% | 1312.96% | -76.52% | -66.83% | 171.75% | -81.44% | 286.16% | -15.27% | 40.1% | 174.62% | -237.94% | -22.27% | -166.63% | -148.15% | -50.31% | 124.03% | 59.82% |
| D&A (Non-Cash Add-back) | 239M | 260M | 249M | 251M | 244M | 269M | 259M | 259M | 272M | 266M | 283M | 300M | 304M | 306M | 321M | 358M | 323M | 320M | 329M | 305M |
| EBIT | 638M | 372M | 855M | 406M | 519M | 893M | -52M | -13M | -217M | 1.25B | 344M | 670M | 499M | -892M | 418M | 651M | -713M | -89M | 710M | 582M |
| Net Interest Income | -201M | -292M | -209M | -203M | -225M | 763M | -272M | -241M | -250M | -260M | -280M | -268M | -260M | -280.25M | -252M | -211M | -258M | -180M | -241M | -274M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 201M | 292M | 209M | 203M | 225M | -763M | 272M | 241M | 250M | 260M | 280M | 268M | 260M | 280.25M | 252M | 211M | 258M | 180M | 241M | 274M |
| Other Income/Expense | -216M | -209M | -234M | -251M | -225M | -218M | -270M | -239M | -253M | -248M | -280M | -237M | -221M | -245M | -254M | 1.59B | -237M | -253M | -244M | -263M |
| Pretax Income | 436M | 91M | 648M | 204M | 294M | -247M | -321M | -244M | -471M | 508M | 64M | -891M | -234M | -1.1B | 165M | 641M | -950M | -175M | 379M | 319M |
| Pretax Margin % | 10.95% | 1.93% | 14.46% | 4.89% | 7.56% | -5.84% | -7.41% | -5.86% | -12.33% | 11.4% | 1.66% | -22.98% | -6.39% | -28.33% | 4.59% | 16.93% | -25.95% | -4.27% | 9.75% | 8.16% |
| Income Tax | 67M | -390M | 214M | -78M | 74M | 28M | 69M | 630M | -52M | 41M | -12M | 16M | 19M | 154M | 107M | 900M | 2M | -24M | 76M | 98M |
| Effective Tax Rate % | 15.37% | -428.57% | 33.02% | -38.24% | 25.17% | -11.34% | -21.5% | -258.2% | 11.04% | 8.07% | -18.75% | -1.8% | -8.12% | -14% | 64.85% | 140.41% | -0.21% | 13.71% | 20.05% | 30.72% |
| Net Income | 369M | 480M | 433M | 282M | 214M | -217M | -437M | -846M | -139M | 463M | 69M | -872M | -220M | -1.22B | 56M | -232M | -955M | -159M | 292M | 207M |
| Net Margin % | 9.27% | 10.19% | 9.67% | 6.75% | 5.5% | -5.13% | -10.09% | -20.32% | -3.64% | 10.39% | 1.79% | -22.49% | -6.01% | -31.44% | 1.56% | -6.13% | -26.09% | -3.88% | 7.51% | 5.29% |
| Net Income Growth % | 72.43% | 321.2% | 199.08% | 133.33% | 253.96% | -146.87% | -733.33% | 2.98% | 36.82% | 137.92% | 23.21% | -275.86% | 76.96% | -667.92% | -80.82% | -212.08% | -1340.26% | -206% | 106.71% | 47.86% |
| Net Income (Continuing) | 369M | 481M | 434M | 282M | 220M | -275M | -390M | -874M | -419M | 467M | 76M | -907M | -253M | -1.25B | 58M | -259M | -952M | -151M | 303M | 221M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4M | 4M | 4M | 7M | 7M | 347M | 319M | 204M | 265M | 620M | 582M | 656M | 751M | 794M | 751M | 791M | 916M | 966M | 984M | 987M |
| EPS (Diluted) | 0.31 | 0.41 | 0.37 | 0.24 | 0.18 | -0.19 | -0.39 | -0.74 | -0.13 | 0.41 | 0.07 | -0.77 | -0.20 | -1.10 | 0.05 | -0.21 | -0.86 | -0.14 | 0.26 | 0.19 |
| EPS Growth % | 72.22% | 315.79% | 194.87% | 132.43% | 238.46% | -146.34% | -653.19% | 3.9% | 35% | 137.27% | 41% | -266.67% | 76.74% | -685.71% | -80.77% | -210.53% | -1328.57% | -200% | 106.55% | 46.15% |
| EPS (Basic) | 0.32 | 0.42 | 0.38 | 0.25 | 0.19 | -0.19 | -0.39 | -0.74 | -0.13 | 0.41 | 0.07 | -0.77 | -0.20 | -1.10 | 0.05 | -0.21 | -0.86 | -0.14 | 0.26 | 0.19 |
| Diluted Shares Outstanding | 1.18B | 1.17B | 1.16B | 1.16B | 1.16B | 1.13B | 1.13B | 1.13B | 1.12B | 1.14B | 1.14B | 1.12B | 1.11B | 1.11B | 1.12B | 1.11B | 1.11B | 1.1B | 1.11B | 1.11B |
| Basic Shares Outstanding | 1.16B | 1.15B | 1.15B | 1.15B | 1.14B | 1.13B | 1.13B | 1.13B | 1.12B | 1.12B | 1.12B | 1.12B | 1.11B | 1.11B | 1.11B | 1.11B | 1.11B | 1.1B | 1.1B | 1.1B |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |